SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

IMR Imricor Medical Systems, Inc.

Healthcare · Medical Devices · website
$1.50
52wk 1.27 – 2.25
Overall
22.3
Value
62.5
Growth
0.0
Health
34.3
Quality
0.0
Momentum
5.0
Dividend
—
Price
About Imricor Medical Systems, Inc.

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. The company through its Imricor Cardiovascular vertical provides integrated single session workflows for hospitals for MR imaging. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Price analytics

Returns

1 day -5.0%
1 week -8.0%
1 month -21.6%
3 months -21.2%
6 months -22.4%
1 year -5.3%
3 years 168.7%

Risk

Volatility (1y ann.) 54.1%
Beta vs ASX 200 1.23
Sharpe (1y) 0.09
VaR 95% (1-day) -5.0%
Max drawdown (1y) -31.6%
Off 1-year high -31.6%

Technicals

RSI(14) 17 OS
vs 50DMA -19.6%
vs 200DMA -19.2%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 62.5
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
0
Price / Sales
0
Growth 0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 34.3
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
54
Debt / Equity
46
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 5.0
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
24

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$539.61M
P/E (trailing)
—
P/E (forward)
-14.09
EPS (trailing)
-0.12
Dividend yield
—
Payout ratio
0.0%
Beta
0.48
EV / EBITDA
-18.99
Price / Book
12.88
ROE
-143.1%
Operating margin
-12,266.4%
Net margin
0.0%
Total cash
$67.46M
Total debt
$34.02M
Current ratio
1.72
Debt / Equity
1.17
Free cash flow
$-10.35M
Avg volume
684,379
Latest annual results (FY ending 31 Dec 2025)
  • Revenue$292.31K
  • Gross profit-$2.03M
  • Operating income-$23.62M
  • Net income-$25.32M
  • Diluted EPS—
  • Free cash flow-$19.52M
  • Net debt$6.46M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4